Target intelligence / Profile preview

50S ribosomal protein L4 and 50S ribosomal protein L32 (L4, L32)

Target
L4, L32
Molecular classification
Ribosomal protein, Structural component of ribosome, Other
01

Overview

The 50S ribosomal subunit is the larger component of the prokaryotic 70S ribosome and functions as the site of peptide bond formation during translation. **50S ribosomal protein L4** is a highly conserved protein located near the peptidyl transferase center and the exit tunnel; it interacts with rRNA and is involved in both ribosome assembly and the catalysis of peptide bond formation. L4 also has secondary roles in feedback regulation of ribosomal protein operon expression, and its structure features distinctive RNA-binding domains and protein–protein interaction sites[1][6]. **50S ribosomal protein L32** is a small, basic protein component of the 50S subunit that helps stabilize ribosomal structure by binding rRNA, although it does not have a direct functional role in catalysis. Both L4 and L32 are essential for correct ribosome assembly and function. Mutations in L4, in particular, are associated with antibiotic resistance, as this region of the ribosome is a major target for several clinically important antibiotics[1]. The combined targeting of these proteins is not standard, as they are distinct structural entities within the ribosome.

Other names
L4: Ribosomal protein L4rplD (gene symbol in bacteria)L32: Ribosomal protein L32rplF (gene symbol in bacteria)
02

Mechanism of action

Inhibition of protein synthesis by binding to the 50S subunit, often at or near the peptidyl transferase center or the nascent peptide exit tunnel (L4 contribution) Disruption of ribosomal assembly and mRNA translation

03

Biological functions

Protein synthesis (translation)Structural stabilization of ribosomePeptidyl transferase activity (L4, specifically)rRNA binding
04

Disease associations

Infection (as bacterial ribosomal proteins are targeted by antibiotics); no direct human disease roles, but inhibition leads to antibacterial effects
05

Safety considerations

Target selectivity (antibiotic targeting of bacterial, not eukaryotic, ribosomes)Development of drug resistance (mutations in L4, for example, confer resistance to macrolides)
06

Interacting drugs

Macrolide antibiotics (e.g., erythromycin, clarithromycin, azithromycin; primarily target or interact with the L4-containing region)

3 more in the full profile.

07

Biomarkers

Mutations in the rplD (L4) gene can be used as biomarkers for macrolide antibiotic resistance in clinical microbiologyNo established clinical biomarkers for L32

Beyond the preview

Go deeper on 50S ribosomal protein L4 and 50S ribosomal protein L32 (L4, L32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 50S ribosomal protein L4 and 50S ribosomal protein L32 (L4, L32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call